North American pharma growing by overseas acquisitions

Tuesday, May 31, 2011 03:24 PM

European drugmakers have more competition for nearby buyouts these days, according to a report on FiercePharma. With North America's pharma companies turning to international markets for growth, they're scouting Central Europe, Eastern Europe, Turkey and the Middle East for potential generics deals, which is likely to push prices upward, experts told Dow Jones.

Most recent Central European pharma deals went to a European drugmaker or an Indian company, according to investment bankers. Now, North American companies are making acquisitions, such as Canadian drugmaker Valeant Pharmaceuticals' buyout of Lithuania's AB Sanitas and U.S.-based Watson Pharmaceuticals' purchase of Greece's Specifar.

Dow Jones said not only were the winning bidders in these deals North American, but the entire bidding pool was dominated by North American companies. That trend hasn't gone unnoticed in the M&A community; UBS has identified 17 pharma companies in "local" emerging markets that could be acquisition targets, including Hungary's Gedeon Richter and Hikma Pharmaceuticals of Jordan.

Share:          
CWWeekly

March 30

Icon, Carnegie Mellon partner to research ways to improve study patients' understanding of Informed Consent

Veeva launches OpenKey, partner program to unlock difficult access to, restrictions on customer reference data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs